Last reviewed · How we verify
fluidotherapy with ringer-lactate
fluidotherapy with ringer-lactate is a Crystalloid intravenous fluid Small molecule drug developed by Medical University of Vienna. It is currently FDA-approved for Hypovolemia and dehydration management, Perioperative fluid replacement, Burn injury fluid resuscitation.
Fluidotherapy with Ringer-lactate is an intravenous fluid replacement therapy that restores intravascular volume and electrolyte balance in dehydrated or hypovolemic patients.
Fluidotherapy with Ringer-lactate is an intravenous fluid replacement therapy that restores intravascular volume and electrolyte balance in dehydrated or hypovolemic patients. Used for Hypovolemia and dehydration management, Perioperative fluid replacement, Burn injury fluid resuscitation.
At a glance
| Generic name | fluidotherapy with ringer-lactate |
|---|---|
| Sponsor | Medical University of Vienna |
| Drug class | Crystalloid intravenous fluid |
| Modality | Small molecule |
| Therapeutic area | Critical Care / Emergency Medicine / Perioperative Medicine |
| Phase | FDA-approved |
Mechanism of action
Ringer-lactate is a crystalloid solution containing sodium, potassium, calcium, chloride, and lactate in physiologic concentrations. When administered intravenously, it replaces lost fluids and electrolytes, restores circulating blood volume, and maintains cellular function. The lactate component is metabolized by the liver to bicarbonate, providing mild alkalinizing effects.
Approved indications
- Hypovolemia and dehydration management
- Perioperative fluid replacement
- Burn injury fluid resuscitation
- Hemorrhagic shock management
Common side effects
- Hyperkalemia (in renal impairment)
- Fluid overload / pulmonary edema
- Hyperchloremic acidosis (with large volumes)
- Phlebitis at infusion site
Key clinical trials
- Goal Directed Fluid Therapy (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- fluidotherapy with ringer-lactate CI brief — competitive landscape report
- fluidotherapy with ringer-lactate updates RSS · CI watch RSS
- Medical University of Vienna portfolio CI
Frequently asked questions about fluidotherapy with ringer-lactate
What is fluidotherapy with ringer-lactate?
How does fluidotherapy with ringer-lactate work?
What is fluidotherapy with ringer-lactate used for?
Who makes fluidotherapy with ringer-lactate?
What drug class is fluidotherapy with ringer-lactate in?
What development phase is fluidotherapy with ringer-lactate in?
What are the side effects of fluidotherapy with ringer-lactate?
Related
- Drug class: All Crystalloid intravenous fluid drugs
- Manufacturer: Medical University of Vienna — full pipeline
- Therapeutic area: All drugs in Critical Care / Emergency Medicine / Perioperative Medicine
- Indication: Drugs for Hypovolemia and dehydration management
- Indication: Drugs for Perioperative fluid replacement
- Indication: Drugs for Burn injury fluid resuscitation
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing